172 related articles for article (PubMed ID: 36870694)
1. Oncogenes and Methionine Addiction of Cancer: Role of
Aoki Y; Han Q; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023; 20(2):165-170. PubMed ID: 36870694
[TBL] [Abstract][Full Text] [Related]
2. Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation.
Aoki Y; Han Q; Tome Y; Yamamoto J; Kubota Y; Masaki N; Obara K; Hamada K; Wang JD; Inubushi S; Bouvet M; Clarke SG; Nishida K; Hoffman RM
Front Oncol; 2022; 12():1009548. PubMed ID: 36408173
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of
Aoki Y; Kubota Y; Han Q; Masaki N; Obara K; Bouvet M; Chawla SP; Tome Y; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):679-685. PubMed ID: 38035708
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells.
Holtz AG; Lowe TL; Aoki Y; Kubota Y; Hoffman RM; Clarke SG
PLoS One; 2023; 18(12):e0296291. PubMed ID: 38134182
[TBL] [Abstract][Full Text] [Related]
5. Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction.
Yamamoto J; Aoki Y; Inubushi S; Han Q; Hamada K; Tashiro Y; Miyake K; Matsuyama R; Bouvet M; Clarke SG; Endo I; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(1):12-18. PubMed ID: 34949655
[TBL] [Abstract][Full Text] [Related]
6. Oral-recombinant Methioninase Lowers the Effective Dose and Eliminates Toxicity of Cisplatinum for Primary Osteosarcoma of the Mammary Gland in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Wu NF; Samonte C; Wu J; Hozumi C; Obara K; Kubota Y; Aoki Y; Miyazaki J; Hoffman RM
In Vivo; 2022; 36(6):2598-2603. PubMed ID: 36309364
[TBL] [Abstract][Full Text] [Related]
7. Deletion of
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564
[TBL] [Abstract][Full Text] [Related]
8. Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Samonte C; Wu NF; Hozumi C; Wu J; Obara K; Kubota Y; Aoki Y; Bouvet M; Hoffman RM
Anticancer Res; 2022 Nov; 42(11):5217-5222. PubMed ID: 36288875
[TBL] [Abstract][Full Text] [Related]
9. Effective Metabolic Targeting of Human Osteosarcoma Cells
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
[TBL] [Abstract][Full Text] [Related]
10. Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells.
Yamamoto J; Aoki Y; Han Q; Sugisawa N; Sun YU; Hamada K; Nishino H; Inubushi S; Miyake K; Matsuyama R; Bouvet M; Endo I; Hoffman RM
Anticancer Res; 2021 Feb; 41(2):641-643. PubMed ID: 33517268
[TBL] [Abstract][Full Text] [Related]
11. Melittin Inhibits Growth of Human Osteosarcoma 143B Cells through Induction of Apoptosis
Xie X; Li Y; Zhu H; Chen L; Chen D; Lin S; Fan T
Anticancer Agents Med Chem; 2022; 22(18):3172-3181. PubMed ID: 35579132
[TBL] [Abstract][Full Text] [Related]
12. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
13. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.
Luu HH; Kang Q; Park JK; Si W; Luo Q; Jiang W; Yin H; Montag AG; Simon MA; Peabody TD; Haydon RC; Rinker-Schaeffer CW; He TC
Clin Exp Metastasis; 2005; 22(4):319-29. PubMed ID: 16170668
[TBL] [Abstract][Full Text] [Related]
14. Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):731-737. PubMed ID: 35093871
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
[TBL] [Abstract][Full Text] [Related]
16. [RHPN2 is highly expressed in osteosarcoma cells to promote cell proliferation and migration and inhibit apoptosis].
Liu Z; Fang F; Li J; Zhao G; Zang Q; Zhang F; Die J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1367-1373. PubMed ID: 36210710
[TBL] [Abstract][Full Text] [Related]
17. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Dai G; Zheng D; Guo W; Yang J; Cheng AY
Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
[TBL] [Abstract][Full Text] [Related]
18. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.
Brennecke P; Arlt MJ; Muff R; Campanile C; Gvozdenovic A; Husmann K; Holzwarth N; Cameroni E; Ehrensperger F; Thelen M; Born W; Fuchs B
PLoS One; 2013; 8(9):e74045. PubMed ID: 24040160
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
20. Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Bouvet M; Nishida K; Hoffman RM
Biochem Biophys Rep; 2021 Dec; 28():101177. PubMed ID: 34877414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
